BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Biotech Beach

  Agilent Technologies is Most Sustainable Health Care Company, Survey Shows

  Agilent is one of seven health care companies to make the fourth annual list of 100 companies compiled by the publication.

  February 19, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Astellas Delivers Positive Phase III Results for Severe Menopausal Hot Flashes

  Moderate to severe vasomotor symptoms (VMS), also known as hot flashes, have long been a problem by people facing menopause.

  February 19, 2021

   · 

  2 min read

   · 

  Kristiane Polido
• 

  Policy

  Immunocore’s TCR Bispecific Tebentafusp Earns Breakthrough Designation for Ocular Cancer

  The tebentafusp has earned a breakthrough designation for ocular cancer. The company is planning regulatory filings in the U.S. later this year and in Europe thereafter.

  February 19, 2021

   · 

  2 min read

   · 

  Mark Zipkin
• 

  BioCapital

  COVID-19 Update: Novavax, Bill Gates, J&J and More

  There’s plenty of COVID-19-related news today. Here’s a look.

  February 19, 2021

   · 

  6 min read

   · 

  Mark Terry
• 

  Job Trends

  Novartis’ CAR T Reimbursement Strategy Finds Sweet Spot Between Value and Price

  Novartis managed to bridge the gap between evidence of efficacy and value in this space with a variety of value-based pricing plans developed with regional payers.

  February 19, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  Drug Development

  Clinical Catch-Up: February 15-19

  It was a busy week for clinical trial announcements. Here’s a look.

  February 19, 2021

   · 

  8 min read

   · 

  Mark Terry
• 

  Policy

  AbbVie Settles Botox Rival IP Lawsuit with Evolus

  AbbVie and its partner company, Medytox of South Korea, have settled a years-long intellectual property legal dispute with California’s Evolus over Jeuveau, a potential rival to AbbVie’s blockbuster Botox, which it gained through the acquisition of Allergan.

  February 19, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Novavax Preps to Distribute 1.1 Billion COVID-19 Vaccine Doses Worldwide

  The vaccine will be manufactured and distributed around the world by Novavax and Serum Institute of India (SII).

  February 19, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Foresite Capital Jumps Back Into SPAC Frenzy With Second Shell Company

  The new company, FS Development II, announced this week it raised $175 million in an upsized offering at $10 per share. The shares will be listed on the Nasdaq under the ticker symbol FSII.

  February 19, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  AMR Action Fund Taps Henry Skinner to Lead, Secures New Investment Dollars

  The AMR Action Fund is ramping up its infrastructure – announcing yesterday that former Novartis Venture Funds Head, Henry Skinner, will take the helm as the organization’s first chief executive officer.

  February 19, 2021

   · 

  3 min read

   · 

  Heather McKenzie